Dolutegravir Resistance Emerges in Sub-Saharan Africa HIV Treatment
Scientists have detected emerging drug resistance to dolutegravir, the cornerstone HIV treatment used across multiple Sub-Saharan African countries. While the WHO-recommended regimen maintains a high viral suppression rate above 90% for adherent patients, new data reveal resistance mutations in populations with prior treatment experience, prompting urgent calls for enhanced surveillance. Antiretroviral therapy has transformed HIV … Read more